Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.959 | 1 | 1 | 1984 | 2019 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 1984 | 2013 | ||||||||
|
complement factor B | 0.532 | 0.769 | 4.7E-16 |
|
disease | 0.140 | None | 0.857 | 3 | 7 | 1985 | 2015 | ||||||||
|
major histocompatibility complex, class II, DO alpha | 0.509 | 0.808 | 3.0E-10 |
|
disease | 0.140 | None | 1.000 | 3 | 10 | 1986 | 2016 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.500 | None | 0.967 | 2 | 2 | 1986 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 4 | 1986 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.500 | None | 0.960 | 1 | 1 | 1986 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.923 | 1 | 2 | 1987 | 2016 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.500 | None | 0.974 | 1 | 3 | 1987 | 2020 | ||||||||
|
tyrosinase | 0.473 | 0.808 | 5.0E-32 |
|
disease | 0.500 | None | 0.984 | 4 | 2 | 1988 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.500 | None | 0.938 | 3 | 62 | 1988 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.948 | 3 | 3 | 1988 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.968 | 2 | 2 | 1988 | 2019 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 1.000 | strong | 0.980 | 2 | 2 | 1988 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.991 | 1 | 1 | 1988 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.946 | 1 | 5 | 1988 | 2020 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.958 | 1 | 2 | 1988 | 2019 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
group | 0.500 | None | 0.976 | 1 | 3 | 1988 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 6 | 4 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.946 | 2 | 1 | 1989 | 2019 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.500 | None | 0.958 | 2 | 2 | 1989 | 2020 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 1989 | 2019 | |||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 1989 | 2011 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.110 | None | 1.000 | 1 | 5 | 1989 | 2007 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.200 | None | 0.972 | 1 | 2 | 1989 | 2019 |